Loading...
XKRX
195870
Market cap674mUSD
Jul 10, Last price  
59,400.00KRW
1D
13.36%
1Q
8.20%
Jan 2017
358.69%
IPO
286.97%
Name

Haesung DS Co Ltd

Chart & Performance

D1W1MN
XKRX:195870 chart
P/E
42.39
P/S
1.55
EPS
1,401.22
Div Yield, %
1.35%
Shrs. gr., 5y
Rev. gr., 5y
7.33%
Revenues
653.40b
+8.36%
165,198,409,270246,043,242,380276,195,590,230325,060,603,310363,290,231,270381,400,318,000458,746,168,000655,373,013,000839,357,973,000672,245,278,000602,993,604,000653,396,882,000
Net income
23.82b
-59.42%
20,227,858,00014,687,201,00018,866,847,00023,978,413,00020,844,384,00018,332,215,00029,989,720,00071,261,705,000159,399,506,00084,426,426,00058,697,149,00023,820,804,000
CFO
66.96b
+10.46%
10,429,405,16029,819,609,45016,403,337,82023,658,688,47036,762,813,33033,520,291,00044,378,902,00057,112,624,000196,854,232,000143,107,280,00060,622,309,00066,962,775,000
Dividend
Dec 29, 2025800 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

HAESUNG DS Co., Ltd., a South Korean-based enterprise, specializes in the global manufacturing and sale of semiconductor components. Its product offerings include lead frames, which are vital for applications in the automotive industry, mobile technology, personal computing, and various consumer electronics. The company also supplies package substrates critical for flash memory, mobile DRAM, and graphic DRAM, alongside graphene, which finds utility across sectors such as energy, sensors, biotechnology, military applications, inks, and display technologies. Furthermore, HAESUNG DS is actively developing bio-healthcare sensors, engineered to track physical activity and health conditions, with a focus on their integration into wearable devices and other IT products. Founded in 1984, the company's headquarters are situated in Seoul, South Korea.
IPO date
Jun 24, 2016
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT